Related by context. All words. (Click for frequent words.) 71 terlipressin 70 Orphan Therapeutics 70 Cx# [002] 69 Alvesco R 69 Cellegesic 69 Initiates Clinical 69 Loramyc R 69 LEVADEX TM 68 Taiho Pharmaceutical 68 Icatibant 68 Receives Orphan Drug Designation 68 Ceflatonin R 68 topical NSAID 67 NDA Submission 67 Initiates Phase II 67 SYCREST 67 Sanvar 67 Granted Orphan Drug 67 Retacrit 67 Argatroban 67 PREOS R 67 MOVIPREP R 67 Initiate Clinical Trial 67 Zirgan 66 Oracea ® 66 NUEDEXTA ™ 66 Kuvan R 66 Somatuline Depot 66 Successfully Completes Phase 66 Initiates Phase III 66 JOULFERON 66 Qutenza TM 66 HuMax TAC 66 PHX# 66 Orapred ODT 66 SAFLUTAN 66 Files IND 66 Nipent R 66 Initiates Enrollment 66 Orphan Designation 66 Evoltra 66 Preotact R 66 Invicorp R 66 Loramyc ™ 66 Meets Primary Endpoint 66 Firazyr 66 Vernalis plc 66 Kineret R 66 Crofelemer budesonide foam 66 Albugon 66 Civacir 66 Somatuline R Autogel R 65 Medidur ™ FA 65 AMITIZA ® 65 Actemra tocilizumab 65 BLP# Liposome Vaccine 65 PDE4 inhibitor 65 Completes Patient Enrollment 65 Syntonix 65 STEDESA 65 Flutiform TM 65 Kissei Pharmaceutical 65 Indaflex 65 UPLYSO 65 Receives Marketing Authorization 65 Files Investigational 65 Indaflex TM 65 Zenpep 65 Receives Orphan Drug 65 Loramyc 65 Clolar ® 65 tiapamil 65 Testim R 65 Archexin 65 methylnaltrexone bromide 65 Soliris eculizumab 65 rasagiline tablets 65 Receives Fast Track 65 XIAFLEX ® 65 Alfa Wassermann 65 MKC# MKC# PP 65 Fresenius Biotech 65 Ophthotech 65 Frova ® 65 Preotact 65 vapreotide acetate 65 Trobalt 65 Initiates Clinical Trial 65 RECOTHROM R 65 COLAZAL R 65 intravenous AAT 65 Emezine 65 Gentamicin Surgical Implant 65 Sylvie Gregoire President 65 IMPACS R 65 IV Busulfex 65 Rectogesic 64 drug ISA# 64 FOLOTYN ® 64 HuMax 64 Catena ® 64 Cetrorelix 64 Amrubicin 64 BEMA Fentanyl 64 Myocet 64 Panzem R 64 Zelrix 64 Urocidin TM 64 Fabry Disease 64 RECOTHROM ® 64 methylnaltrexone 64 Alvesco ® 64 Receives Approvable Letter 64 Receive Milestone Payment 64 adenosine A2A 64 ATG Fresenius S 64 Ecallantide 64 Orphan Status 64 Campath ® 64 REMICADE infliximab 64 Fodosine 64 Collategene 64 Pirfenidone 64 Pennsaid ® 64 Drug Eluting Stent System 64 Dyloject TM 64 Eraxis 64 SANVAR 64 Abstral ® 64 Patient Enrollment 64 ZALBIN 64 Loramyc TM 64 DepoBupivacaine TM 64 Lubiprostone 64 Kissei Pharmaceuticals 64 L BLP# 64 Granulocyte Colony Stimulating Factor 64 BEMA Granisetron 64 Apokyn 64 Initiate Phase 64 Prism Pharmaceuticals 64 Fenoglide 64 LibiGel ® 64 BENLYSTA ® 64 CIP TRAMADOL ER 64 Tezampanel 64 Prestara 64 CDP# 64 Allovectin 7 R 64 Rapinyl 64 Fortigel 64 Personalized Immunotherapy 64 Orphan Drug designations 64 POSIDUR TM 64 beta 1a 64 Zorbtive TM 64 HuMax CD4 64 Angiox 64 LEVADEX ™ 64 Aloxi ® 64 ProFibrix 64 Insegia 64 Maxy G# 64 BRILINTA 64 Tostrex 64 EvaMist TM 64 Kuvan TM sapropterin 64 Synvisc ONE 63 BioDelivery Sciences Announces 63 NeuroSTAT ® 63 Silodosin 63 Glassia 63 DepoDur 63 Raptiva R 63 Initiates Clinical Trials 63 Fast Track Status 63 Nabi HB Intravenous 63 Pennsaid R 63 Aryplase 63 Rescula 63 inhaled AAT 63 Transdermal Patch 63 ZYFLO R 63 ZARS Pharma 63 Aviptadil 63 Uvidem 63 GLASSIA 63 Phase III Trial 63 SUMAVEL 63 Receives CE Marking 63 Esmya 63 successfully commercialize Iluvien 63 FACTIVE R gemifloxacin 63 JAK2 Inhibitor 63 P#X# antagonist 63 VISICOL R 63 FDA Approvals 63 Ercole Biotech 63 Ascend Therapeutics 63 Glufast 63 PRIALT 63 Submits NDA 63 Viralytics 63 Biliary System 63 Pegloticase 63 HepeX B 63 Marketing Authorisation Application 63 Daclizumab 63 Iluvien TM 63 reslizumab 63 Phase III Pivotal 63 volociximab 63 Busulfex 63 ularitide 63 TRANSDUR Bupivacaine 63 Plicera 63 Spiegelmer ® 63 ABILIFY R 63 rhMBL 63 VIVITROL ® 63 ALVESCO R 63 SomatoKine 63 Factor VIIa 63 PrandiMet 63 epoprostenol sodium 63 Dupuytren Contracture 63 molecular imaging radiopharmaceutical 63 SPRYCEL ® 63 Kyowa Kirin 63 Pivotal Trial 63 XIAPEX 63 Akesis Pharmaceuticals 63 SynthRx 63 Meritage Pharma 63 DiaPep# 63 Milestone Payment 63 highly selective adenosine 63 OMAPRO ™ 63 Raptiva ® 63 Sigma Tau Pharmaceuticals 63 Orphan Drug status 63 Xenazine ® 63 Phase III Clinical Trial 63 BEXXAR 63 NPS NPS Pharmaceuticals 63 atacicept 63 FDA APPROVES 63 Auxilium Pharma 63 balsalazide tablet 63 Achieves Primary Endpoint 63 ORTHOCON 63 Testosterone Gel 63 Neulasta R 63 LymphoStat B TM 63 PDUFA Date 63 TRANSDUR ™ 63 Vaccinex 63 Alnara Pharmaceuticals 63 Gelclair 63 label Lipofen R 62 alvimopan 62 Alexion Soliris 62 Eluting Coronary Stent System 62 personalized cellular immunotherapy 62 cathepsin K inhibitor 62 OMNARIS Nasal Spray 62 Pulmonary Arterial Hypertension 62 Alferon N 62 Psoriasis Drug 62 RhuDex 62 aerosolized AAT 62 Seikagaku Corporation 62 Japanese Encephalitis Vaccine 62 Proquin XR 62 Elagolix 62 Tracleer r 62 ABILIFY ® 62 Zenapax 62 Nippon Shinyaku 62 TRISENOX ® 62 Surfaxin LS 62 DUROS 62 Nabi HB R 62 XAGRID 62 Betaseron ® 62 Drug Candidate 62 sumatriptan DosePro 62 Xerecept 62 GW# [003] 62 Desvenlafaxine 62 GATTEX TM 62 Xcytrin R 62 voclosporin 62 Multiferon R 62 KAI Pharmaceuticals 62 Maribavir 62 Fortical R 62 KIACTA TM 62 Phusion Laboratories 62 Oasmia 62 Cytokine PharmaSciences 62 Onco TCS 62 diarrhea predominant irritable 62 Evoltra ® 62 EnzymeRx 62 Ception Therapeutics 62 thetreatment 62 Laboratoires Thea 62 vinorelbine tartrate 62 Arno Therapeutics 62 Sublinox 62 Orphan Drug Status 62 Iluvien ® 62 Cinryze ™ 62 Tobira Therapeutics 62 CONBRIZA 62 liver resection surgeries 62 CAMPATH 62 Investigational Treatment 62 Yondelis ® 62 JAK Inhibitor 62 Patient Enrolment 62 Pivotal Study 62 ENTOCORT EC 62 Lupin Pharmaceuticals 62 acetonide FA 62 Entocort 62 Ganciclovir 62 FDA Orphan Drug 62 NitroMist 62 MacroMed 62 Voraxaze 62 Psivida 62 novel oral anticoagulant 62 FUSILEV ® 62 XYOTAX TM 62 EpiCeram 62 rilonacept 62 Galantamine 62 SARcode 62 RHEI Pharmaceuticals 62 Begins Dosing 62 ENTEREG ® 62 topical ophthalmic 62 selective immunoproteasome inhibitor 62 DP VPA 62 bardoxolone 62 Gamunex C 62 LEUKINE 62 AERx iDMS 62 ASX PGL 62 Xanafide 62 Increlex TM 62 induced macular edema 62 Dantrium R 62 Degarelix 62 Ambrisentan 62 Surgical Sealant 62 Seikagaku 62 nasal calcitonin product 62 VYVANSE TM lisdexamfetamine 62 BYETTA ® 62 Sanvar R 62 commercialize AzaSite 62 Solorel ® 62 ChronTech 62 Urokinase 62 Combunox 62 Ceplene histamine dihydrochloride 62 Kepivance 62 glucokinase activator 62 Nexavar ® 62 Valtropin 62 elbion 62 IV APAP 62 HepaSphere 62 Levoleucovorin 62 Onalta 62 BioGeneriX 62 SNT MC# 62 Serdolect ® 62 BioNumerik 62 StaphVAX R 62 Sensipar R 62 faropenem 62 Angiox ® 62 NEBIDO R 62 STELARA TM 62 Oral Spray 62 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 62 Inhalation Aerosol 62 Solasia 62 PrevOnco ™ 62 Lovaza TM 62 PGL# 62 Fludara ® 62 Multiferon 62 HaptoGuard 62 Firazyr ® 62 Commences Phase 62 Thelin tm 62 Xyntha 62 REPLAGAL 62 Somatuline R Depot 62 JAK inhibitor 62 Intravenous Human 62 Luveniq 62 ProEthic Pharmaceuticals 62 HQK 62 epoetin zeta 62 Bendamustine 62 Receives Milestone Payment 62 cinacalcet HCl 62 rhFVIIa 62 investigational pharmacologically unique 62 Savella ® 62 BioSante Pharmaceuticals Announces 62 Inhalation Solution 62 Submits Biologics License Application 62 Transcept Pharmaceuticals 62 Cinryze TM 62 Thrombin topical Recombinant 62 Liprotamase 62 prostone 62 Skin Cholesterol Test 62 Milestone Payments 62 Firdapse 62 Fujisawa Healthcare Inc. 62 acyclovir Lauriad R 62 Apaziquone 62 FIRAZYR 62 Yentreve 62 Interferon Alpha 62 Abbokinase 62 MERREM 62 Febuxostat 62 Dermylex TM 62 ONCASPAR 62 XIAFLEX ™ 62 Vascular Wrap TM 62 Veregen TM 62 Zentaris 62 Combidex 62 Demonstrates Significant 62 FlexStent ® 62 Tesamorelin 62 InvaGen 62 Synera 62 pegylated interferon lambda 61 Recombinant Human 61 ZADAXIN ® 61 SinuNase TM 61 GRAS Status 61 Bremelanotide 61 Wellstat 61 ALN PCS 61 Verus Pharmaceuticals 61 LIVALO 61 Initiates Phase 2b 61 rxRNA 61 Thrombin 61 treat chronic sinusitis 61 KuDOS 61 oral salmon calcitonin 61 ZEVALIN ® 61 Zebinix R 61 commercialize dutogliptin 61 Adenuric ® 61 R bendamustine hydrochloride 61 Moxifloxacin 61 Cerimon 61 YONDELIS 61 targeted radiotherapeutic 61 Serostim ® 61 Multiple Ascending Dose 61 RESOLOR 61 CRMD# 61 Aggrastat 61 PDX pralatrexate 61 CCX# B 61 Iloperidone 61 HCl Tablets 61 PecFent 61 Æterna Zentaris 61 Ozarelix 61 Epiphany Biosciences 61 Apokyn R 61 5 HT3 antagonist 61 TH# [003] 61 Glufosfamide 61 Aloxi R 61 developing TB4 61 Systemic Delivery 61 Calixa Therapeutics 61 albiglutide 61 Telatinib 61 PSN# [001] 61 Campto 61 StemEx 61 Surgical Mesh 61 mitiglinide 61 Vernakalant 61 Tetrabenazine 61 BioDelivery 61 Prometheus Laboratories 61 amifampridine phosphate 61 PROMUS TM 61 Stanate R 61 Functional Dyspepsia 61 Lung Rx 61 orphan designation 61 Vaprisol 61 Targeted Chemotherapy 61 ALN HPN 61 THALOMID 61 Traficet EN 61 rhIGF-I/rhIGFBP-3 61 XIENCE V Everolimus Eluting 61 Proprius Pharmaceuticals 61 Certican 61 Dynogen 61 Tibotec BVBA 61 proteasome inhibitor 61 Orphan Drug designation 61 Presents Preclinical 61 Patent Covering 61 Bioral Amphotericin B 61 Cefepime 61 FDA Approvable Letter 61 markets HP Acthar 61 oral taxane 61 Testosterone MDTS ® 61 MERREM IV 61 FDA Accepts 61 Anturol TM 61 anti CD# monoclonal 61 AVAPRO 61 EGRIFTA TM 61 Prestara TM 61 BioGlue ® 61 XIAFLEX TM 61 RhuDex ® 61 CIMZIA r 61 BAL# [002] 61 CyDex Pharmaceuticals 61 Kalbitor 61 Benicar HCT 61 GTC recombinant form 61 Cellgate 61 FluoroPharma 61 Promedior 61 Medisorb R 61 Initiate Phase II 61 liposomal formulation 61 Daniel Tasse 61 RELISTOR ® 61 Vegenics 61 Emselex 61 FOR FURTHER INFORMATION ABOUT 61 KALBITOR ® 61 Juvantia 61 Xanthus Pharmaceuticals Inc. 61 Spirus Medical 61 MuGard TM 61 R sorafenib tablets 61 AMPYRA ® 61 RELOVAIR ™ 61 Oracea TM 61 Bazedoxifene 61 Expedited Review 61 romazarit 61 Adenosine Therapeutics 61 IMiD 61 Omalizumab 61 Creabilis Therapeutics 61 Presents Preclinical Data 61 Dual Opioid TM 61 Initiates Dosing 61 Syncria R 61 BUPHENYL R 61 ALVESCO ® 61 RAPAFLO 61 PreHistin TM 61 Wafer polifeprosan 61 FS Antihemophilic Factor Recombinant 61 Prolongs Survival 61 E1 INT TM 61 ONGLYZA ™ 61 PrevOnco 61 Pafuramidine 61 Oryx Pharmaceuticals 61 dihydrochloride 61 Oral Insulin 61 Chrysalin 61 Alzhemed TM 61 registrational studies 61 Onconase 61 Sanctura XR 61 Cimzia TM 61 Ustekinumab 61 Evoltra TM 61 CVac 61 Urocidin 61 Uracyst R 61 NTDDS 61 Ventavis 61 Twinject ® 61 INOmax 61 mesylate 61 Olmesartan 61 WILEX 61 Lysteda 61 Orally administered 61 Enzyme Replacement Therapy 61 Eximias Pharmaceutical Corporation 61 GenWay Biotech 61 Ciclesonide 61 Ceflatonin ® 61 Sirion Therapeutics 61 mGluR2 positive 61 lomitapide 61 Phase IIB 61 PREOS 61 Myrexis Inc. 61 erlotinib Tarceva R 61 Loxapine 61 Mepact 61 apaziquone 61 Angioblast 61 Cinacalcet HCl 61 ATryn ® 61 Genzyme Myozyme 61 Peginterferon alfa 2b 61 Paladin Labs 61 TolerRx 61 Loramyc ® 61 Lexiscan R 61 Alferon N Injection 61 Cardio Vascu Grow 61 SOLVAY PHARMACEUTICALS 61 GeneraMedix Inc. 61 BXT # 61 neurogenic orthostatic hypotension 61 tramiprosate ALZHEMED TM 61 sterile lidocaine patch 61 ZEFTERA TM Zevtera TM 61 Saizen R 61 Biopartners 61 Generx ® 61 SURFAXIN 61 Phase 2a Trial 61 KRYSTEXXA TM pegloticase 61 MAXY VII 61 Marketing Authorization 61 miconazole Lauriad R 61 Ore Pharmaceuticals 61 adenosine injection 61 Onalta TM 61 Taligen Therapeutics 61 VALSTAR TM 61 Monovisc 61 Xeloda ® 61 human C1 inhibitor 61 Nitec 61 Zenyaku Kogyo 61 Pulmonx 61 PEGylated anti 61 equine osteoarthritis marketed 61 LUNESTA ® 61 CD# monoclonal antibody 61 Oglemilast 61 Phase IIb Clinical Trial 61 SinuNase ™ 61 IMiDs 61 Romiplostim 61 Veronate R 61 Etravirine 61 Vertex retains 61 novel prodrug 61 Phase IIb Trial 61 Stragen 61 PROVENGE ® 61 Neupogen ® 61 Pimavanserin 61 Helsinn 61 Xyrem ® 61 Anidulafungin 61 YONDELIS R 61 Xolegel 61 TAXUS TM 61 lucinactant 61 VivaGel ™ 61 OLEPTRO TM 61 LHRH antagonist 61 Receives Positive Opinion 61 Shigamabs R 61 Covalon Technologies 61 Junovan TM 61 BLA filing 61 octreotide implant 61 Lodotra 61 Eligard R 61 histamine dihydrochloride 61 Vivecon 61 outlicensed 61 Tyzeka Sebivo 61 targeted antifolate 61 Tracleer R 61 candidate deforolimus 61 Valortim TM 61 Simulect 61 fipamezole 61 INTEGRILIN 60 Pivotal Phase III 60 Saxagliptin 60 Commence Phase 60 R MSCRAMM 60 Oxytrol R 60 HuLuc# 60 PERLANE 60 SYGNIS 60 Present Preclinical Data 60 Octreotide 60 AZILECT ® 60 Liberte TM 60 Ozurdex 60 ViroChem Pharma Inc. 60 RIGScan CR 60 SBL Vaccines 60 Mipomersen 60 Lispro 60 ARRY # 60 Hexvix ® 60 Xyzal R 60 EKR Therapeutics 60 immatics 60 Hsp# Inhibitor 60 Panzem ® 60 Naglazyme R 60 eprodisate KIACTA TM 60 TRANSDUR ® 60 CE Marked 60 PhosLo R 60 candidate Gencaro TM 60 dutogliptin 60 Handok 60 dimesylate 60 selective estrogen receptor modulator 60 Sinuwave 60 HyACT 60 Gleevec imatinib mesylate 60 injectable bulking agent 60 GeneraMedix 60 Remicade infliximab 60 Neurodex 60 Submits Response 60 Cimzia certolizumab pegol 60 Announces Poster Presentations 60 Nitazoxanide 60 Doripenem 60 Polymer Microspheres 60 Virium 60 SCHWARZ PHARMA 60 Somatuline ® Depot 60 Fast Track Designation 60 Sufentanil 60 Cethrin R 60 Azmacort 60 LymphoStat B belimumab 60 BEMA TM Fentanyl 60 BCG refractory carcinoma 60 Apokyn ® 60 Supernus Pharmaceuticals Inc. 60 AGGRASTAT ® 60 Meda STO MEDAA 60 Bosutinib 60 SUTENT ® 60 Bayer Onyx 60 GA GCB 60 cicletanine 60 XIENCE 60 Lexiscan TM 60 GHIS 60 Announce License Agreement 60 Micromet BiTE 60 Regeneron Pharma 60 ELAPRASE 60 Ketotransdel 60 Glybera R 60 oral prodrug 60 CEDAX ® 60 Zensana TM 60 Microwave Ablation System 60 HalcyGen 60 oncolytic virus therapies 60 TRISENOX R 60 Aphthasol R 60 Neulasta ® 60 IL# PE#QQR 60 Trandolapril 60 synthetic peptide containing 60 Increlex R 60 Brilique 60 Initiates Phase 60 lexidronam injection 60 GEMS TM 60 XP# XP# 60 Canadian drugmaker Aeterna 60 Vascugel 60 Luitpold Pharmaceuticals 60 fostamatinib 60 GTC recombinant human 60 Reacquires 60 AnGes 60 Daytrana ® 60 NanoTab 60 fluvoxamine maleate 60 PEGylated Fab fragment 60 INT# [002] 60 Adamis Pharmaceuticals 60 Phase 2b Clinical Trial 60 Mylan Receives Approval 60 Luteinizing Hormone Releasing Hormone 60 product Fentanyl TAIFUN 60 tetrabenazine 60 Completes Enrollment 60 ORENCIA R 60 topical non steroidal 60 CureDM 60 thalidomide Thalomid 60 Troxatyl 60 diclofenac sodium 60 Trastuzumab DM1 60 XIAPEX ® 60 plus DOXIL 60 albinterferon alfa 2b 60 CytoFab 60 AzaSite Plus 60 TKPHF 60 pain palliation 60 vosaroxin 60 Valera Pharmaceuticals 60 Selective Electrochemical Tumor Ablation 60 Sopherion 60 Evoltra R 60 MKC# 60 Nexavar sorafenib tablets 60 Renvela ® 60 Clinical Study Shows 60 Sunesis Pharmaceuticals 60 Alaven 60 Bioral 60 BioGeneriX AG 60 ATryn ® GTC recombinant 60 IPM Wound Gel 60 Sumatriptan Succinate 60 Expanded Indication 60 Tripep 60 Anticancer Agent 60 ReFacto 60 IPLEX 60 Antisense Pharma GmbH 60 miconazole MBT 60 DepoDur TM 60 commercialize telaprevir 60 IND Application 60 Glatiramer Acetate 60 Oral Calcitonin 60 Ridaforolimus 60 Roche OTC RHHBY 60 Acute Attacks 60 Lexiscan ® 60 miconazole Lauriad ® 60 Juvaris BioTherapeutics 60 NAVISTAR R 60 Glypromate 60 ™ Everolimus Eluting 60 orphan medicinal product 60 Chemokine 60 Fibrillex TM 60 ZFP Therapeutics 60 Oral Cladribine 60 OMNARIS HFA 60 Bepreve TM 60 VentiRx Pharmaceuticals 60 Teva Provides Update 60 Soriatane 60 humanized anti 60 Oxxon 60 OZURDEX 60 granulated mesalamine 60 Metaphore 60 Efficacy Trial 60 RNAi Therapeutic 60 INTEGRILIN R eptifibatide Injection 60 markets Testim ® 60 Excellarate TM 60 ONTAK 60 Tiuxetan 60 DIFICID ™ 60 Fentanyl Taifun 60 Liprostin 60 ™ Paclitaxel Eluting 60 SPL# Gel vaginal microbicide 60 Pacira Pharmaceuticals 60 mertansine 60 pioglitazone HCl 60 Behcet uveitis 60 Therapeutic Competitors Companies 60 Zingo TM 60 Stromedix 60 ANTEGREN 60 Protease Inhibitor 60 Severe Sepsis 60 Bicifadine 60 Gleevec Glivec 60 BioTie 60 ELADUR TM 60 Ferumoxytol 60 Marqibo TM 60 BioSTAR R 60 GLP1 INT TM 60 TRACON Pharmaceuticals 60 Adnectin 60 candidate TNFerade biologic 60 TELINTRA R 60 Guerbet 60 Lumacan 60 Irinotecan 60 Milestone Payment From 60 Synerx Pharma 60 DORIBAX 60 SILENOR 60 Grants Orphan Drug 60 recombinant biopharmaceutical 60 TM Everolimus Eluting 60 AMRIX 60 Arcalyst 60 Sycrest 60 JCR Pharmaceuticals 60 Copegus R 60 Teflaro 60 doxercalciferol 60 Fx #A 60 Plenaxis R 60 regadenoson 60 Presents Positive Preclinical 60 Archemix Corp. 60 Orencia abatacept 60 Lupus Drug 60 Stressgen 60 PROMUS R 60 Nippon Kayaku 60 RxKinetix 60 ABELCET 60 LUVENIQ 60 FlutiformTM 60 Sanochemia 60 KNS # 60 Perforomist ™ Inhalation Solution 60 selective A2A adenosine receptor 60 NeuroSolutions 60 ARIXTRA R 60 Diamyd Medical Diamyd 60 motexafin gadolinium Injection 60 Idera Pharmaceuticals 60 Inhibitor Human 60 vitreoretinal disorders 60 thrombolytic agent 60 Fumapharm 60 PANVAC VF 60 AMEX RGN 60 highly purified pasteurized 60 Mersana 60 Portola Pharmaceuticals 60 anti CD3 monoclonal 60 Zeneus 60 Acetavance TM 60 Phenoptin 60 Medidur FA 60 Nautilus Biotech 60 Axentis Pharma 60 BCR ABL inhibitors 60 EVICEL 60 Amplimexon 60 herpetic keratitis 60 Ixempra 60 Microplasmin 60 Efficacy Results 60 severe gastroparesis 60 AVASTIN 60 Australian Therapeutic Goods 60 ospemifene 60 First Patient Enrolled 60 Keppra XR 60 Liestal Switzerland 60 delivers fluocinolone acetonide FA 60 VALSTAR 60 BiDil XR